SLC16A1 and neoplasm: Extensive research has elucidated that MCT1 and its mediated substrate transport not only sustain tumor progression through the maintenance of metabolic symbiosis but also promote angiogenesis, suppress the immune response of relevant immune cells, and engage in additional mechanisms that are conducive to tumor progression.